Ventyx Biosciences: Why Caution Should Remain [Seeking Alpha]
Ventyx Biosciences, Inc. (VTYX)
Company Research
Source: Seeking Alpha
VTYX's VTX3232 lowered hsCRP and IL-6, suggesting cardiometabolic benefits, but trial design and biomarker specificity raise concerns about translatability. A short cash runway and heavy reliance on VTX3232's success create significant risk; future trial outcomes will heavily impact the stock. Richard Drury/DigitalVision via Getty Images On October 22, Ventyx Biosciences ( VTYX shared the top-line results of their Phase 2 study investigating VTX3232. Initially designed to decipher if the compound was able to reduce weight as a monotherapy or This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Pas
Show less
Read more
Impact Snapshot
Event Time:
VTYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTYX alerts
High impacting Ventyx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
VTYX
News
- Ventyx Provides Clinical and Corporate UpdatesGlobeNewswire
- Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in LondonGlobeNewswire
- Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Wells Fargo & Company from $11.00 to $14.00. They now have an "overweight" rating on the stock.MarketBeat
VTYX
Earnings
- 11/6/25 - Beat
VTYX
Sec Filings
- 11/26/25 - Form SCHEDULE
- 11/19/25 - Form 4
- 11/19/25 - Form 4
- VTYX's page on the SEC website